Før behandling startes med AVAGLIM skal en klinisk evaluering af patientens risiko for at udvikle hypoglykæmi foretages (se afsnit 4. 4).
Before therapy is initiated with AVAGLIM appropriate clinical evaluation should be made to assess the patient’ s risk of developing hypoglycaemia (see section 4.4).